Patents-Review.com
ClassID:

20287 ⎘

A61K31/34 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

Sub-classes:
Recent Application in this class:
#1
20260041730
2026-02-12

COMPOSITIONS FOR DRINKING WATER

 #2
20250387390
2025-12-25

METHODS FOR TREATING FIBROSIS USING PKM2 ACTIVATORS

 #3
20250312306
2025-10-09

Concentrate comprising a semiochemical composition

 #4
20250302794
2025-10-02

COMPOSITIONS, METHODS AND SYSTEMS FOR THE TREATMENT OF CUTANEOUS DISORDERS

 #5
20250281521
2025-09-11

COMPOSITIONS FOR THE TREATMENT OF DRY EYE

 #6
20250268859
2025-08-28

OXAFURAMINE, (1R)-N-ETHYL-1-[(2R)-OXOLAN-2-YL]-2-PHENYLETHANAMINE, HYDROCHLORIDE AND DERIVATIVES THEREOF FOR TREATING ALZHEIMER'S DISEASE (AD), VASCULAR DEMENTIA, DEMENTIA WITH LEWY BODIES (DLB), MIXED DEMENTIA, FRONTOTEMPORAL LOBAR DEGENERATION (FTLD), AND PARKINSON'S DISEASE (PD)

 #7
20250228831
2025-07-17

METHOD TO PREVENT AND TREAT GLAUCOMA BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS

 #8
20250228778
2025-07-17

PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION

 #9
20250208149
2025-06-26

WEE1 COMPOUND FOR TREATING UTERINE SEROUS CARCINOMA

 #10
20250205276
2025-06-26

COMPOSITIONS AND METHODS OF TREATMENT OF DISEASE USING COMBINATION OF A NITRODILATOR AND A NITROGEN OXIDE COMPOUND

 #11
20250170090
2025-05-29

METHOD FOR PREVENTING OR TREATING DISEASE OR DISORDER ASSOCIATED WITH ANTINEOPLASTIC AGENT

 #12
20250144157
2025-05-08

GLYCAN STRANDS AND OLIGOSACCHARIDES DERIVED FROM STREPTOCOCCUS BACTERIA

 #13
20250144075
2025-05-08

Melanin for treating lipofuscin-associated diseases

 #14
20250134829
2025-05-01

LOW-DOSE, STABLE-RELEASE TRANSDERMAL PREPARATION AND PATCH, AND METHOD FOR THEIR PRODUCTION

 #15
20250064844
2025-02-27

N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO

 #16
20250064772
2025-02-27

TREATMENT OF CARDIAC DYSFUNCTION

 #17
20240409657
2024-12-12

COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS

 #18
20240366538
2024-11-07

Hepatitis B Antiviral Agents

 #19
20240350569
2024-10-24

Nutritional Composition

 #20
20240316018
2024-09-26

CAPSID INHIBITORS FOR THE TREATMENT OF HIV

 #21
20240207233
2024-06-27

MEDICAMENT

 #22
20240122963
2024-04-18

COMPOSITIONS FOR THE TREATMENT OF DRY EYE

 #23
20240050375
2024-02-15

MASKING THE TASTE OF ISOSORBIDE

 #24
20240041864
2024-02-08

METHODS FOR TREATING SOFT TISSUE SARCOMA

 #25
20230330128
2023-10-19

OLIGOMERS HAVING BICYCLIC SCAFFOLD MOIETIES

 #26
20230321139
2023-10-12

Wound-care composition and method of use

 #27
20230293697
2023-09-21

Method for stabilization and delivery of therapeutic molecules

 #28
20230293522
2023-09-21

HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME

 #29
20230293452
2023-09-21

RESTORING PHYSIOLOGY IN IRON-DEFICIENT ORGANISMS USING SMALL MOLECULES

 #30
20230241012
2023-08-03

Hepatitis B antiviral agents

 #31
20230167126
2023-06-01

Compositions and methods for treating atopic dermatitis

 #32
20230167125
2023-06-01

Compositions and methods for treating atopic dermatitis

 #33
20230157991
2023-05-25

PHARMACEUTICAL COMPOSITION FOR TREATING ACUTE AND CHRONIC PAIN, CONTAINING POLMACOXIB AND TRAMADOL

 #34
20230115867
2023-04-13

Pemafibrate dosing regimens

 #35
20230113424
2023-04-13

Nutritional composition

 #36
20230112980
2023-04-13

Compounds and compositions for inducing chondrogenesis

 #37
20230101803
2023-03-30

3CLPRO-TARGETING PHILLYRIN, DERIVATIVE THEREOF, AND USE THEREOF AGAINST NOVEL CORONAVIRUS

 #38
20230095075
2023-03-30

COMPOSITIONS AND METHODS TO PROTECT MAMMALIAN TISSUE AGAINST COLD AND OTHER METABOLIC STRESSES

 #39
20230013402
2023-01-19

REGENERATING FUNCTIONS AND PHENOTYPES OF CONNECTIVE TISSUE THROUGH NPAS2 SUPPRESSION

 #40
20220362385
2022-11-17

Method for stabilization and delivery of therapeutic molecules

 #41
20220331316
2022-10-20

HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME

 #42
20220331285
2022-10-20

COMPOSITION FOR PREVENTING OR TREATING NEUROPATHIC PAIN, CONTAINING SYRINGARESINOL

 #43
20220313650
2022-10-06

METHODS FOR TREATING NEURODEVELOPMENTAL DISORDERS

 #44
20220296588
2022-09-22

Pemafibrate dosing regimens

 #45
20220257627
2022-08-18

Pemafibrate dosing regimens

 #46
20220251103
2022-08-11

Compositions and methods for treating atopic dermatitis

 #47
20220235066
2022-07-28

Oxabicycloheptane prodrugs

 #48
20220202772
2022-06-30

COMPOSITIONS AND METHODS FOR INHIBITING RIBOSOME INACTIVATING PROTEINS

 #49
20220193025
2022-06-23

USE OF DIANHYDROHEXITOL TO ELIMINATE THE COSMETIC EFFECTS OF ACNE, DANDRUFF AND BAD ODORS

 #50
20220175863
2022-06-09

Compositions and methods useful in treatment of lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction, and other diseases or symptoms

 #51
20220168369
2022-06-02

Nutritional composition

 #52
20220142967
2022-05-12

Methods and Compositions for the Treatment of Multiple Sclerosis

 #53
20220096523
2022-03-31

COMPOSITIONS FOR THE TREATMENT OF DRY EYE

 #54
20220096424
2022-03-31

Treatment of cardiac dysfunction

 #55
20220096417
2022-03-31

INDUCTION OF ARTERIOGENESIS WITH AN NO (NITRIC OXIDE) DONOR

 #56
20220087970
2022-03-24

PREVENTION OF ANESTHETIC-INDUCED NEUROCOGNITIVE DYSFUNCTION

 #57
20210403434
2021-12-30

Metabolically stable 5-HMF derivatives for the treatment of hypoxia

 #58
20210386703
2021-12-16

COMPOSITIONS, METHODS AND SYSTEMS FOR THE TREATMENT OF CUTANEOUS DISORDERS

 #59
20210346335
2021-11-11

Methods of using nitric oxide donor compounds for treatment of COVID-19 and other infectious diseases

 #60
20210322397
2021-10-21

METHOD TO PREVENT AND TREAT GINGIVAL RECESSION BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS

 #61
20210322395
2021-10-21

METHOD TO PREVENT AND TREAT HEARING LOSS BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS

 #62
20210322361
2021-10-21

METHOD OF PREVENTING OR TREATING SIDE EFFECT OF TUMOR THERAPY

 #63
20210299118
2021-09-30

Coordinated metabolic reprogramming in response to productive viral infections

 #64
20210299038
2021-09-30

METHOD TO PREVENT AND TREAT OCULAR CATARACT BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS

 #65
20210290590
2021-09-23

METHODS OF TREATING SUBJECTS INFECTED WITH HIV

 #66
20210283205
2021-09-16

Nutritional composition

 #67
20210283147
2021-09-16

17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure

 #68
20210283095
2021-09-16

Detection and Treatment of Viral Diseases and Cancer

 #69
20210283077
2021-09-16

Hepatitis B antiviral agents

 #70
20210252033
2021-08-19

N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO

 #71
20210251955
2021-08-19

PREVENTION OF AGE RELATED CLONAL HEMATOPOIESIS AND DISEASES ASSOCIATED THEREWITH

 #72
20210244749
2021-08-12

DARUNAVIR FORMULATIONS

 #73
20210187042
2021-06-24

Glycan strands and oligosaccharides derived from bacteria

 #74
20210177758
2021-06-17

Platform drug delivery system utilizing crystal engineering and theanine dissolution

 #75
20210137934
2021-05-13

METHODS OF IDENTIFYING MYC-DRIVEN AND LIPOGENESIS-DEPENDENT NEOPLASMS AND METHODS OF TREATING THE SAME

 #76
20210113596
2021-04-22

Glycan therapeutics and method of treating conditions associated with TMAO

 #77
20210106671
2021-04-15

TREATMENT AND PREVENTION OF PLANTAR WARTS

 #78
20210106646
2021-04-15

Combination Of A Novel Topical Gel And Oral Supplements For Healing Diabetic Foot And Other Wounds

 #79
20210069185
2021-03-11

USE OF FLIBANSERIN IN THE TREATMENT OF OBESITY

 #80
20210069108
2021-03-11

METHODS FOR PREVENTION AND TREATMENT OF PRESSURE ULCERS CAUSED BY ISCHEMIA USING CONTACT VASODILATORS

 #81
20210069102
2021-03-11

METHODS FOR PREVENTION AND TREATMENT OF UROGENITAL ATROPHY OF MENOPAUSE BY CONTACT VASODILATORS

 #82
20210046023
2021-02-18

Persistent topical antimicrobial compositions and methods of using the same

 #83
20210040133
2021-02-11

FOOD OR FEED COMPOSITION FOR IMPROVING COGNITIVE FUNCTION OR MEMORY COMPRISING EXTRACT OF DESALTED SALICORNIA EUROPAEA

 #84
20210038619
2021-02-11

Pharmaceutical compositions

 #85
20210024462
2021-01-28

SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

 #86
20210002291
2021-01-07

Isoidide derivatives and methods of making and using same

 #87
20210000859
2021-01-07

COMPOSITIONS FOR THE TREATMENT OF DRY EYE

 #88
20200368230
2020-11-26

Compositions and methods to protect mammalian tissue against cold and other metabolic stresses

 #89
20200361893
2020-11-19

Polysubstituted benzene, preparation method thereof, and method of using the same

 #90
20200330654
2020-10-22

Degradable removable implant for the sustained release of an active compound

 #91
20200325151
2020-10-15

Oxabicycloheptane prodrugs

 #92
20200276254
2020-09-03

Nutritional composition

 #93
20200276152
2020-09-03

PHARMACEUTICAL COMPOSITION FOR TREATING ACUTE AND CHRONIC PAIN, CONTAINING POLMACOXIB AND TRAMADOL

 #94
20200255373
2020-08-13

SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

 #95
20200253915
2020-08-13

Method of preventing or treating side effect of tumor therapy

 #96
20200237737
2020-07-30

Compounds and compositions for inducing chondrogenesis

 #97
20200237689
2020-07-30

PREVENTION AND TREATMENT OF CORONAVIRUS AND OTHER RESPIRATORY INFECTIONS USING NANOEMULSION COMPOSITIONS

 #98
20200230042
2020-07-23

1,4: 3,6 dianhydrohexitols for moisturising the skin

 #99
20200223845
2020-07-16

Viral replication inhibitors

 #100
20200181162
2020-06-11

Compositions and methods for restoring epidermal integrity and function and treating dermatological diseases

 #101
20200179375
2020-06-11

Formulations of oxabicycloheptanes and oxabicycloheptenes

 #102
20200121750
2020-04-23

Compositions and methods useful in treatment of lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction and other diseases or symptoms

 #103
20200121620
2020-04-23

SENOLYTIC COMPOUNDS

 #104
20200113873
2020-04-16

MEDICAMENT

 #105
20200101093
2020-04-02

Methods of Treating and Preventing Neuropsychiatric and/or Neurocognitive Complications in Patients Infected with HIV

 #106
20200093851
2020-03-26

Glycan therapeutics and related methods thereof

 #107
20200093845
2020-03-26

Glycan therapeutics and related methods thereof

 #108
20200085821
2020-03-19

Heteroaryl compounds useful as inhibitors of SUMO activating enzyme

 #109
20200069805
2020-03-05

PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE

 #110
20200038389
2020-02-06

Capsid inhibitors for the treatment of HIV

 #111
20200038363
2020-02-06

Composition for preventing or treating neurological and mental disorders, containing syringaresinol

 #112
20200022935
2020-01-23

TOPICAL FORMULATION FOR TREATING BRUISING

 #113
20200000754
2020-01-02

Viscoelastic solution and use thereof in rhumatology

 #114
20190382414
2019-12-19

Isoidide derivatives and methods of making and using same

 #115
20190380969
2019-12-19

Controlled Release Compositions Comprising A Combination Of Isosorbide Dinitrate And Hydralazine Hydrochloride

 #116
20190374500
2019-12-12

Process for Preparing Water Soluble Azadiractin Powder Formulation with In-Built and External Inclusion Complexes

 #117
20190365903
2019-12-05

Method for stabilization and delivery of therapeutic molecules

 #118
20190365693
2019-12-05

INDUCTION OF ARTERIOGENESIS

 #119
20190359627
2019-11-28

Oxabicycloheptane prodrugs

 #120
20190358282
2019-11-28

Compositions and methods useful in treatment of lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction and other diseases or symptoms

 #121
20190343760
2019-11-14

Topical regional neuro affective therapy with cannabinoid combination products

 #122
20190336468
2019-11-07

METHODS AND COMPOSITIONS FOR THE TREATMENT OF MULTIPLE SCLEROSIS

 #123
20190314348
2019-10-17

Compounds and compositions for inducing chondrogenesis

 #124
20190284121
2019-09-19

Anhydrosugar alcohol composition having enhanced storage stability, and anhydrosugar alcohol storage method

 #125
20190282566
2019-09-19

Use of Flibanserin in the treatment of obesity

 #126
20190282536
2019-09-19

Method for preventing or treating diseases associated with the inhibition of EGFR

 #127
20190247419
2019-08-15

COMPOSITIONS FOR THE TREATMENT OF DRY EYE

 #128
20190209520
2019-07-11

PHARMACOLOGICAL TREATMENT OF COGNITIVE IMPAIRMENT

 #129
20190201353
2019-07-04

AGENT FOR IMPROVING CAROTENOID BALANCE IN BLOOD

 #130
20190194241
2019-06-27

Pharmaceutical composition for preventing or treating dementia and improving cognitive function, comprising glasswort extract

 #131
20190175635
2019-06-13

Application of a phillyrin/phillygeninin composition in preparing a medicine or health care product for alleviating or/and treating viral diseases, and medicine or health care product for treating viral diseases

 #132
20190175511
2019-06-13

A Multi-Class Anti-Retroviral Composition

 #133
20190175508
2019-06-13

Anti-retroviral compositions

 #134
20190167671
2019-06-06

Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes

 #135
20190167632
2019-06-06

METHODS OF TREATING AND PREVENTING/REDUCING THE LIKELIHOOD OF MESIAL TEMPORAL LOBE EPILEPSY (TLE)

 #136
20190167578
2019-06-06

Transmucosal Delivery of Terpenes Via Edible Film

 #137
20190134012
2019-05-09

Compounds and compositions for inducing chondrogenesis

 #138
20190117714
2019-04-25

Use of a composition for lowering cholesterol level in a mammal, a method for its preparation and a product and a food additive comprising said composition

 #139
20190117687
2019-04-25

Cognitive function-remedying agent

 #140
20190117615
2019-04-25

Treatment of cardiac dysfunction

 #141
20190083387
2019-03-21

Topical regional neuro-affective therapy with cannabinoid combination products

 #142
20190060258
2019-02-28

Hepatitis B antiviral agents

 #143
20190046525
2019-02-14

Protein phosphatase 2A inhibitors for treating myelodysplastic syndromes

 #144
20190040076
2019-02-07

Spirocyclic quinolizine derivatives useful as HIV integrase inhibitors

 #145
20190038687
2019-02-07

Nutritional composition

 #146
20180369243
2018-12-27

FUSED BICYCLIC PYRIMIDINE DERIVATIVES AND USES THEREOF

 #147
20180362540
2018-12-20

Compound for inhibiting binding between DX2 protein and p14/ARF protein, and pharmaceutical composition for treating or preventing cancer disease containing same as effective ingredient

 #148
20180353561
2018-12-13

Pharmaceutical composition for preventing and treating chronic obstructive lung disease containing, as active ingredient, extract, fraction, or active fraction thereof

 #149
20180325927
2018-11-15

Amido-substituted pyridotriazine derivatives useful as HIV integrase inhibitors

 #150
20180311239
2018-11-01

Heteroaryl compounds useful as inhibitors of sumo activating enzyme

 #151
20180280326
2018-10-04

MEDICAMENT FOR PREVENTING OR INHIBITING ACUTE KIDNEY INJURY

 #152
20180263926
2018-09-20

Restoring physiology in iron-deficient organisms using small molecules

 #153
20180256663
2018-09-13

Compositions and methods useful in treatment of lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction and other diseases or symptoms

 #154
20180250276
2018-09-06

Antibacterial compounds

 #155
20180244690
2018-08-30

Oxabicycloheptane prodrugs

 #156
20180235926
2018-08-23

Methods for controlling the spread of dirofilariosis

 #157
20180153894
2018-06-07

Fused bicyclic pyrimidine derivatives and uses thereof

 #158
20180153830
2018-06-07

SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS

 #159
20180127361
2018-05-10

Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B

 #160
20180110724
2018-04-26

FILM DOSAGE FORM WITH MULTIMODAL AND PARTICLE SIZE DISTRIBUTIONS

 #161
20180099053
2018-04-12

PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE

 #162
20180092856
2018-04-05

COMPOSITIONS AND METHODS FOR ADMINISTRATION TO SUBJECTS WITH DYSPHAGIA

 #163
20180085340
2018-03-29

Method for treating melanoma

 #164
20180064660
2018-03-08

AMINO ALCOHOL DERIVATIVES FOR THE TREATMENT OF DEMYELINATING PERIPHERAL NEUROPATHIES

 #165
20180064649
2018-03-08

PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION

 #166
20180050011
2018-02-22

Inflammasome activation in myelodysplastic syndromes

 #167
20180037344
2018-02-08

Process for packaging a dianhydrohexitol, aqueous solution of dianhydrohexitol packaged and uses thereof

 #168
20180028554
2018-02-01

Oligomers Having Bicyclic Scaffold Moeities

 #169
20180028500
2018-02-01

Azabenzimidazole derivatives as agonists of the AMP-activated protein kinase

 #170
20180021296
2018-01-25

Potentiated antimicrobial agents

 #171
20180015084
2018-01-18

Use of flibanserin in the treatment of obesity

 #172
20170360798
2017-12-21

ANAVEX2-73 AND CERTAIN ANTICHOLINESTERASE INHIBITORS COMPOSITION AND METHOD FOR NEUROPROTECTION

 #173
20170354634
2017-12-14

Combinations of prostaglandins and nitric oxide donors

 #174
20170340628
2017-11-30

Protein phosphatase 2A inhibitors for treating myelodysplastic syndromes

 #175
20170333398
2017-11-23

Heterocyclic derivative having AMPK-activating activity

 #176
20170327517
2017-11-16

Boronic Acid Inhibitors of HIV Protease

 #177
20170320886
2017-11-09

Cortistatin analogues and syntheses thereof

 #178
20170312296
2017-11-02

Agents for killing HIV-1-infected cells and application thereof

 #179
20170312217
2017-11-02

INHALATION-TYPE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GOUT AND PREPARATION METHOD THEREOF

 #180
20170305952
2017-10-26

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

 #181
20170304293
2017-10-26

Coordinated metabolic reprogramming in response to productive viral infections

 #182
20170281587
2017-10-05

ERYTHROCYTE FUNCTION IMPROVING AGENT

 #183
20170275263
2017-09-28

Compounds for the treatment of HPV-induced carcinoma

 #184
20170273935
2017-09-28

CINEOLE-CONTAINING COMPOSITION FOR NASAL APPLICATION

 #185
20170239259
2017-08-24

ARYLOXY PHENOXY ACRYLIC COMPOUND HAVING HIF-1 INHIBITION ACTIVITY, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS AN ACTIVE INGREDIENT

 #186
20170239227
2017-08-24

Compounds and compositions for inducing chondrogenesis

 #187
20170232025
2017-08-17

Application of a phillyrin/phillygeninin composition in preparing a medicine or health care product for alleviating or/and treating viral diseases, and medicine or health care product for treating viral diseases

 #188
20170231950
2017-08-17

Composition and method to treat and alleviate symptoms of hot flashes in a female subject

 #189
20170218068
2017-08-03

Method for the identification of immunotherapy-drug combinations using a network approach

 #190
20170216290
2017-08-03

Heteroaryl compounds useful as inhibitors of SUMO activating enzyme

 #191
20170209440
2017-07-27

Methods and compositions for treating HIV-related disorders

 #192
20170209412
2017-07-27

Treatment of sickle cell disease

 #193
20170209381
2017-07-27

Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride

 #194
20170172966
2017-06-22

Induction of arteriogenesis with an NO (nitric oxide) donor

 #195
20170151299
2017-06-01

EXTRACTS OF SANTOLINA CHAMAECYPARISSUS

 #196
20170128471
2017-05-11

Combination therapy to treat mycobacterium diseases

 #197
20170105958
2017-04-20

USE OF A FEED COMPOSITION FOR REDUCING METHANE EMISSION IN RUMINANTS, AND/OR TO IMPROVE RUMINANT PERFORMANCE

 #198
20170100414
2017-04-13

Small molecule efflux pump inhibitors

 #199
20170095561
2017-04-06

Method for stabilization and delivery of therapeutic molecules

 #200
20170081339
2017-03-23

Compositions and methods for restoring epidermal integrity and function and treating dermatological diseases

 #201
20170066778
2017-03-09

SOLUBILITY FOR TARGET COMPOUNDS

 #202
20170027904
2017-02-02

Composition and method to treat and alleviate symptoms of hot flashes in a female subject

 #203
20170014438
2017-01-19

Anti-esophageal cancer compound and method of use thereof

 #204
20170000759
2017-01-05

Pharmaceutical Composition Including 5--2,2-Dimethyl-4-(3-Fluorophenyl)-3(2H)-Furanone And Capsule Formulation Including The Pharmaceutical Composition

 #205
20160375082
2016-12-29

Lignans isolated from (L.) Thwait

 #206
20160340330
2016-11-24

No-releasing nitrooxy-chromene conjugates

 #207
20160333024
2016-11-17

Oxabicycloheptane prodrugs

 #208
20160324911
2016-11-10

COMPOSITIONS AND METHODS USEFUL IN TREATMENT OF LOWER URINARY TRACT SYMPTOMS, BENIGN PROSTATIC HYPERPLASIA, ERECTILE DYSFUNCTION

 #209
20160317593
2016-11-03

Nutritional composition

 #210
20160297810
2016-10-13

Viral replication inhibitors

 #211
20160296574
2016-10-13

EPHEDRA ALATA EXTRACTS AND METHODS OF USE THEREOF

 #212
20160271053
2016-09-22

Use of stabilized granules containing glyceryl trinitrate for arteriogenesis

 #213
20160263079
2016-09-15

SIRT 1 activator including syringaresinol

 #214
20160263078
2016-09-15

SIRT 1 activator including syringaresinol

 #215
20160263077
2016-09-15

SIRT 1 activator including syringaresinol

 #216
20160256400
2016-09-08

Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride

 #217
20160235706
2016-08-18

Indanyloxydihydrobenzofuranylacetic acids

 #218
20160228402
2016-08-11

Composition containing lignan compound as active ingredient for preventing or treating cancer

 #219
20160213702
2016-07-28

Glycan therapeutics and related methods thereof

 #220
20160213698
2016-07-28

Compositions comprising rutin useful for the treatment of tumors resistant to chemotherapy

 #221
20160213622
2016-07-28

Compositions and methods for administration to subjects with dysphagia

 #222
20160199343
2016-07-14

COMPOUNDS AND FORMULATIONS FOR THE TREATMENT OF WOUNDS

 #223
20160193177
2016-07-07

Compositions, methods and systems for the treatment of cutaneous disorders

 #224
20160136161
2016-05-19

Use of flibanserin in the treatment of obesity

 #225
20160129122
2016-05-12

FATTY ACID ANTIVIRAL CONJUGATES AND THEIR USES

 #226
20160122366
2016-05-05

Boronic acid inhibitors of HIV protease

 #227
20160068804
2016-03-10

Method of molecular stress control

 #228
20160051544
2016-02-25

Formulations of oxabicycloheptanes and oxabicycloheptenes

 #229
20160031898
2016-02-04

Irreversible covalent inhibitors of the GTPase K-Ras G12C

 #230
20150376201
2015-12-31

Cortistatin analogues and syntheses thereof

 #231
20150376113
2015-12-31

Use of nitrooxy organic molecules in feed for reducing methane emission in ruminants, and/or to improve ruminant performance

 #232
20150329554
2015-11-19

Compounds and compositions for inducing chondrogenesis

 #233
20150307510
2015-10-29

Method of making internal dehydration products of sugar alcohols

 #234
20150297508
2015-10-22

Topical Formulation to Enhance Genital Sensation and Function

 #235
20150283110
2015-10-08

Composition for preventing or treating heart disease

 #236
20150283085
2015-10-08

Orally disintegrating tablets and methods of manufacture

 #237
20150274746
2015-10-01

Additives for improved isohexide products

 #238
20150272869
2015-10-01

Inhalation-type pharmaceutical composition for the treatment of arthritis and preparation method thereof

 #239
20150272868
2015-10-01

Inhalation-type pharmaceutical composition for the treatment of heart disease and preparation method thereof

 #240
20150272867
2015-10-01

Inhalation-type pharmaceutical composition for the treatment of Alzheimer's disease and preparation method thereof

 #241
20150272866
2015-10-01

Inhalation-type pharmaceutical composition for the treatment of Parkinson's disease and preparation method thereof

 #242
20150266890
2015-09-24

Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis B

 #243
20150224083
2015-08-13

Cancer Therapy With Cantharidin And Cantharidin Analogs

 #244
20150216985
2015-08-06

ENDOSPORE COMPOSITIONS AND USES THEREOF

 #245
20150196582
2015-07-16

Compositions for the treatment of dry eye

 #246
20150174077
2015-06-25

Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride

 #247
20150148412
2015-05-28

Polymorphs of darunavir

 #248
20150148359
2015-05-28

Selective inhibitors of undifferentiated cells

 #249
20150148353
2015-05-28

Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes

 #250
20150119457
2015-04-30

ESSENTIAL OIL COMPOSITION FROM LEMON PEEL AS GROWTH PROMOTOR IN POULTRY INDUSTRY

 #251
20150110726
2015-04-23

Uses of compounds and mixtures from mycelia

 #252
20150098914
2015-04-09

Glucuronolactone derivatives as self-tanning substances

 #253
20150080407
2015-03-19

Compositions containing riboflavin and sesamin-class compounds

 #254
20150080343
2015-03-19

Benzofuran compounds for the treatment of hepatitis C virus infections

 #255
20150079149
2015-03-19

Dissolvable dietary supplement strip and methods for using the same

 #256
20150065554
2015-03-05

Neurofibromatoses therapeutic agents and screening for same

 #257
20150056299
2015-02-26

FOOD SUPPLEMENT TO SUPPORT BRAIN FUNCTION

 #258
20150030579
2015-01-29

Hydroxytyrosol combinations for enhancing mitochondrial function and energy production

 #259
20150011620
2015-01-08

Anti-invasive compounds

 #260
20150011550
2015-01-08

Methods for treating Alzheimer's disease by administering certain synthetic compounds

 #261
20150005263
2015-01-01

Administration of hypoxia activated prodrugs in combination with Chk1 inhibitors for treating cancer

 #262
20140378466
2014-12-25

DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK

 #263
20140371307
2014-12-18

SIRT 1 activator including syringaresinol

 #264
20140369943
2014-12-18

COMPOSITIONS COMPRISING ISOSORBIDE MONOESTERS AND HALOGENATED ANTIMICROBIAL ACTIVE COMPOUNDS

 #265
20140315996
2014-10-23

Use of isosorbide monoesters as antimicrobial active substances

 #266
20140314882
2014-10-23

Synergistic Combination Therapy

 #267
20140303574
2014-10-09

Adhesive patch assembly with overlay liner and system and method for making same

 #268
20140296799
2014-10-02

Degradable removable implant for the sustained release of an active compound

 #269
20140296333
2014-10-02

Composition of the treatment of vascular diseases or KCa3.1 channel-mediated diseases comprising modafinil or derivatives thereof

 #270
20140296211
2014-10-02

ANAVEX2-73 and certain anticholinesterase inhibitors composition and method for neuroprotection

 #271
20140296210
2014-10-02

Pharmacological treatment of cognitive impairment

 #272
20140248381
2014-09-04

Composition for inhibiting vascular aging comprising syringaresinol

 #273
20140242022
2014-08-28

COMPOSITIONS FOR THE TREATEMENT OF DRY EYE

 #274
20140235649
2014-08-21

USE OF PHOSPHATASE INHIBITORS OR HISTONE DEACETYLASE INHIBITORS TO TREAT DISEASES CHARACTERIZED BY LOSS OF PROTEIN FUNCTION

 #275
20140221474
2014-08-07

Method and Formulation for Chemical Peeling

 #276
20140200356
2014-07-17

Polymorphs of darunavir

 #277
20140170215
2014-06-19

Orally disintegrating tablets and methods of manufacture

 #278
20140154323
2014-06-05

Method for treating bronchial diseases

 #279
20140147529
2014-05-29

Use of nitrooxy organic molecules in feed for reducing methane emission in ruminants, and/or to improve ruminant performance

 #280
20140142174
2014-05-22

DARUNAVIR FORMULATIONS

 #281
20140135373
2014-05-15

Esters of N-acylated derivatives of amino acids and isosorbide, method for preparing same, and use thereof in cosmetics and as drug

 #282
20140094457
2014-04-03

Pharmaceutical compositions and treatment of genetic diseases associated with nonsense mediated RNA decay

 #283
20140088161
2014-03-27

Use of a feed composition for reducing methane emission in ruminants, and/or to improve ruminant performance

 #284
20140066502
2014-03-06

Use of stabilized granules containing glyceryl trinitrate for arteriogenesis

 #285
20140057977
2014-02-27

Induction of Arteriogenesis

 #286
20140045791
2014-02-13

Combination therapy to treat diseases

 #287
20140031290
2014-01-30

GLP-1 receptor stabilizers and modulators

 #288
20140011815
2014-01-09

Fitness assay and associated methods

 #289
20130331383
2013-12-12

Nitrofuran compounds for the treatment of cancer and angiogenesis

 #290
20130317101
2013-11-28

Singleton inhibitors of sumoylation enzymes and methods for their use

 #291
20130317040
2013-11-28

METHODS FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS USING HIV PROTEASE INHIBITORS

 #292
20130295075
2013-11-07

COMPOSITIONS AND METHODS OF TREATING GLAUCOMA

 #293
20130281454
2013-10-24

Prostaglandin and vasoconstrictor pharmaceutical compositions and methods of use

 #294
20130267718
2013-10-10

Amide gellant compositions containing isosorbide

 #295
20130203688
2013-08-08

SUGAR PLANT DERIVED BY-PRODUCTS AND METHODS OF PRODUCTION THEREOF

 #296
20130197075
2013-08-01

Method of treating acquired perforating dermatosis with cantharidin

 #297
20130183257
2013-07-18

COMPOSITIONS AND METHODS FOR IMPROVING SKIN APPEARANCE

 #298
20130131335
2013-05-23

Methods for the preparation of drospirenone and intermediates thereof

 #299
20130131163
2013-05-23

Vitamin C composition for use in the prevention and treatment of stretch marks, radiation dermatitis, and other skin conditions and methods of using the same

 #300
20130131162
2013-05-23

Vitamin C composition for use in the prevention and treatment of stretch marks, radiation dermatitis, and other skin conditions and methods of using the same